V L Serebruany, P A Gurbel. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh： See more » Drug EvaluationFibrinolytic Agents/therapeutic useGene Expression RegulationHumansMyocardial Infarction/bloodMyocardial Infarction/drug therapyMyocardial Infarction/geneticsMyocardial Reperfusion Injury/bloodMyocardial Reperfusion Injury/geneticsP-Selectin/biosynthesisP-Selectin/geneticsPlasminogen Activators/therapeutic usePlatelet Endothelial Cell Adhesion Molecule-1/biosynthesisPlatelet Endothelial Cell Adhesion Molecule-1/geneticsPlatelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitorsPlatelet Glycoprotein GPIIb-IIIa Complex/biosynthesisPlatelet Glycoprotein GPIIb-IIIa Complex/geneticsReceptors, Vitronectin/biosynthesisReceptors, Vitronectin/geneticsRecombinant Proteins/therapeutic useThrombolytic TherapyTissue Plasminogen Activator/therapeutic use
Substances： See more » Fibrinolytic AgentsP-SelectinPlatelet Endothelial Cell Adhesion Molecule-1Platelet Glycoprotein GPIIb-IIIa ComplexReceptors, VitronectinRecombinant ProteinsreteplasePlasminogen ActivatorsTissue Plasminogen Activator
Year: 1999 PMID： 10064014
Source DB: PubMed Journal: Thromb Haemost ISSN： 0340-6245 Impact factor: 5.249